SLC1A5 and melanoma: Yang et al. found that miR-137 can directly target Gln importer SLC1A5, indirectly inhibit glutamine transport and metabolism by inhibiting SLC1A5 or glutamate oxaloacetate transaminase, and ultimately lead to a reduction in ferroptosis in melanoma cells [58].